Important Information for AstraZeneca PLC (NASDAQ:AZN) Investors New York, NY / Access Newswire / January 23, 2025 Are you an investor who has suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment? If so, you may be interested in learning about a potential recovery under the federal securities laws. Joseph E. Levi, Esq. is available…
Welcome to the Future of Applied Materials A Look Into the Future As we step into the year 2025, Applied Materials, Inc. has exciting news to share. The company has just announced that it will be holding its fiscal first quarter earnings conference call on Thursday, February 13th at 4:30 p.m. ET / 1:30 p.m….
Facing a Loss on Your Regeneron Pharmaceuticals Investment? Don’t Worry, You’re Not Alone Hey there, fellow investor! If you’re feeling a bit down about your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment taking a hit, you’re definitely not alone. It happens to the best of us, but the good news is that there may be a potential…
Neptune Digital Assets Corp. Announces Strong Quarter Results Overview Vancouver, British Columbia– (Newsfile Corp. – January 23, 2025) – Neptune Digital Assets Corp. (TSXV: NDA) (OTCQB: NPPTF) (FSE: 1NW) (“Neptune” or the “Company”), a blockchain leader in Canada, is pleased to announce the release of its condensed consolidated interim financial statements and management discussion and…
Military Metals Corp. Files NI 43-101 Technical Report on Trojárová Property Introduction Vancouver, British Columbia–(Newsfile Corp. – January 23, 2025) – Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (the “Company” or “Military”) is pleased to announce that it has filed a NI 43-101 technical report on its 100% owned flagship Trojárová antimony-gold property…
President Trump and the Stock Market: Finding Opportunities in High Valuations The Current State of the Stock Market President Trump has inherited a historically expensive stock market, with the Shiller P/E ratio indicating potentially subdued long-term returns for the S&P 500. Despite these high valuations, there are still opportunities to be found, especially in smaller…
Revolutionizing SMA Treatment: The DEVOTE Study The Potential of Nusinersen’s Higher Dose Regimen Have you heard the buzz about the latest breakthrough in treating Spinal Muscular Atrophy (SMA)? Applications are now being developed based on data from the DEVOTE study, which reveal the exciting potential of an investigational higher dose regimen of nusinersen. For those…
Government Bond ETF: A Stable Investment Option Introduction When it comes to investing in government bonds, one of the top choices for many investors is the Government Bond ETF (GOVT). This ETF offers broad exposure to Treasuries with low interest rate risk and at a low expense ratio of 0.05%. Its performance is consistent with…
